Green Thumb Industries Inc (GTBIF)
6.8700
-0.3500 (-4.85%)
OP · Last Trade: Aug 6th, 7:12 PM EDT
Detailed Quote
| Previous Close | 7.220 |
|---|---|
| Open | 6.890 |
| Bid | - |
| Ask | - |
| Day's Range | 6.510 - 7.420 |
| 52 Week Range | 4.630 - 12.00 |
| Volume | 730,435 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 654,079 |
Chart
News & Press Releases
CHICAGO and VANCOUVER, British Columbia, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today reported its financial results for the quarter ended June 30, 2025. Financial results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”), and all currency is in U.S. dollars.
By Green Thumb Industries · Via GlobeNewswire · August 6, 2025
420 with CNW — Questions Arise on Why Feds Raided a Licensed Cannabis Farm in California
There are thousands of unauthorized cannabis operations across the US. Yet, when federal agents carried out one of their biggest enforcement actions this year, they didn’t target a black-market grower. Instead, they set their sights on California’s largest licensed cannabis producer.
Via CannabisNewsWire · July 25, 2025
420 with CNW — Questions Arise on Why Feds Raided a Licensed Cannabis Farm in California
There are thousands of unauthorized cannabis operations across the US. Yet, when federal agents carried out one of their biggest enforcement actions this year, they didn’t target a black-market grower. Instead, they set their sights on California’s largest licensed cannabis producer.
Via Investor Brand Network · July 25, 2025
420 with CNW — Anxiety Tops Qualifying Conditions in Pennsylvania’s Medical Marijuana Program
Pennsylvania’s move to allow medical cannabis for treating anxiety has significantly influenced how the state’s marijuana program functions, according to a recent University of Pittsburgh study.
Via Investor Brand Network · July 10, 2025
420 with CNW — Anxiety Tops Qualifying Conditions in Pennsylvania’s Medical Marijuana Program
Pennsylvania’s move to allow medical cannabis for treating anxiety has significantly influenced how the state’s marijuana program functions, according to a recent University of Pittsburgh study.
Via CannabisNewsWire · July 10, 2025
Via Benzinga · July 9, 2025
420 with CNW — Marijuana Advocates Express Concerns About the Purchase Rules for Missouri Patients
Medical marijuana advocates are raising concerns about new state guidelines in Missouri that restrict how much cannabis patients can legally buy from dispensaries. Under existing rules, dispensaries must monitor patient purchases to make sure they don’t go over their monthly limits.
Via CannabisNewsWire · June 24, 2025
420 with CNW — Marijuana Advocates Express Concerns About the Purchase Rules for Missouri Patients
Medical marijuana advocates are raising concerns about new state guidelines in Missouri that restrict how much cannabis patients can legally buy from dispensaries. Under existing rules, dispensaries must monitor patient purchases to make sure they don’t go over their monthly limits.
Via Investor Brand Network · June 24, 2025
420 with CNW — Are the Days of THCA Now Numbered?
Steven Brown, the CEO of Nothing But Hemp, believes that THCA flower is legal under federal law due to Farm Bill 2018. But even though his company runs 11 stores across two states and offers a wide range of hemp-derived products, you won’t find THCA flower on his shelves—or his website.
Via Investor Brand Network · June 9, 2025
420 with CNW — Are the Days of THCA Now Numbered?
Steven Brown, the CEO of Nothing But Hemp, believes that THCA flower is legal under federal law due to Farm Bill 2018. But even though his company runs 11 stores across two states and offers a wide range of hemp-derived products, you won’t find THCA flower on his shelves—or his website.
Via CannabisNewsWire · June 9, 2025
Green Thumb (GTI) stood out in Q1 2025 as the only Tier 1 cannabis company to post growth, per a new report from Zuanic & Associates.
Via Benzinga · June 3, 2025
420 with CNW — Studies Suggest Medical Cannabis Could Help Lupus Sufferers
Lupus is a long-term autoimmune condition that affects over 1.5 million people across Canada and the United States. It can lead to widespread inflammation and discomfort, often causing exhaustion, aching joints, rashes, and in more severe cases, damage to internal organs. There’s currently no cure, and the available treatments don’t work for everyone. This has led many people with lupus to seek alternative approaches to managing their symptoms, including medical cannabis.
Via Investor Brand Network · May 27, 2025
420 with CNW — Studies Suggest Medical Cannabis Could Help Lupus Sufferers
Lupus is a long-term autoimmune condition that affects over 1.5 million people across Canada and the United States. It can lead to widespread inflammation and discomfort, often causing exhaustion, aching joints, rashes, and in more severe cases, damage to internal organs. There’s currently no cure, and the available treatments don’t work for everyone. This has led many people with lupus to seek alternative approaches to managing their symptoms, including medical cannabis.
Via CannabisNewsWire · May 27, 2025
Doug Kass says most cannabis stocks are ‘walking dead' — but highlights Trulieve, GTI, TerrAscend and Glass House as top picks for patient investors.
Via Benzinga · May 15, 2025
This week: Q1 earnings reveal a widening market divide, DEA nominee prioritizes rescheduling, and Rove and Swade make big expansion plays.
Via Benzinga · May 9, 2025
GTI, Verano, Cannabist, MariMed, Cronos and IIPR reported Q1 2025 earnings. Here's what happened.
Via Benzinga · May 8, 2025